Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
about
Sublingual immunotherapy for allergic rhinitisSublingual immunotherapy for treating allergic conjunctivitisSublingual immunotherapy for treating allergic conjunctivitisHow does the efficacy and safety of Oralair(®) compare to other products on the market?Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the futureCritical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis.Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?Recommendations for appropriate sublingual immunotherapy clinical trialsBurden of allergic respiratory disease: a systematic reviewSublingual immunotherapy: World Allergy Organization position paper 2013 update.A multicenter, randomized, parallel-group trial assessing compliance, tolerability, safety, and efficacy to treatment with grass allergy tablets in 261 patients with grass pollen rhinoconjunctivitis.Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews.Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in childrenGrass-specific CD4(+) T-cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy.A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitisA prospective study comparing the efficacy and safety of two sublingual birch allergen preparations.Safety, tolerability and efficacy of sublingual allergoid immunotherapy with three different shortened up-dosing administration schedulesSpecific immunotherapy by the sublingual route for respiratory allergy.Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis.Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment.SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma.Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy.Treatment of grass pollen allergy: focus on a standardized grass allergen extract - Grazax®.Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposureThe efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children.In vitro evaluation of allergen potencies of commercial house dust mite sublingual immunotherapy reagentsRobust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.Sublingual immunotherapy in allergic rhinitis."The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoReduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy.Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes.Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study.A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study.ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review.Safety and tolerability of an intra-seasonal initiation of the SQ-standardised grass allergy immunotherapy tablet: a non-interventional observational study investigating the feasibility during routine administration.Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergyEarly compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites.
P2860
Q24235551-569D4E51-8882-4759-B7A5-BCF9F93C938BQ24235657-78EF2D36-C879-4299-9096-831C3DD4581DQ24240628-015D4163-6E0E-41E3-95AA-E3A597A8F338Q26745596-FC6E3FAA-326D-4A1B-BAD7-83A2425EFCF8Q26768511-0A3E603F-FB64-4D4B-A937-C5B2181DE214Q26775905-9DEE0BF0-24B0-4026-8E63-D2FA7A683A16Q26852119-6BA16B41-CE68-46B8-8331-14995963E179Q27011713-6291909A-D2EA-4C5A-9F75-FA30FE2A163CQ28079329-8F618615-42C4-4198-BDB7-ACBC5459B7E9Q30440195-B2695321-3FC0-4D3D-BCCE-F2280B8E3038Q30472704-791F7BAD-A003-4B7E-BC27-A2356FE793A7Q31030974-EA0939F3-1E5D-4154-A533-D9A36B37CA87Q33573199-B74A7774-99E3-4606-8D55-31672FFC922BQ33801094-F8204B32-F2FB-48E3-8B28-2FBCE8130CB5Q33914193-D58BD562-F4A7-4D92-86BD-24C976142C22Q34003337-0F7BD83C-A2D8-4576-8A4A-8EB2EFBFDFB6Q34038666-49337AB9-DDE5-445A-8BC6-E5E95B2202A7Q34353492-2DB49BFA-D3C6-40A3-B95F-478E2F1BF29AQ34521979-054D6CB0-A231-4208-885C-71F6E3F0BF7DQ34522246-AACBF03E-BA7B-41DE-9260-7FC157B52B33Q34577305-6C3DFA4A-C0EF-43C1-8616-15120DC47850Q34580968-C6A4201A-CB71-4E06-BE82-D520E395265EQ34606056-EEBC14D7-9394-4A29-A07B-63F350DFE454Q35040990-4A33B684-7437-4EE6-8F9C-1FF45AA1F5A2Q35078784-84A089B9-68D3-4D45-A62B-276A865D655AQ35123904-DFC23EB2-EA82-4563-984C-35E39F25E7AEQ35199270-D8293715-18A3-4123-A962-B076A470C38BQ35502433-61BCCC4E-87E8-4E2A-9B65-6B780C19ABC1Q35564301-BB916BCB-7C26-49B0-96AD-0DD5233E50C5Q35777126-377D943D-DFCD-4DA6-AC07-D44D02663F20Q36024279-F233C19E-AB18-49DC-8CB5-EE2F99C212A9Q36371027-233716AD-CA65-4260-AC4B-823D5C4FF9D9Q36379784-36A21209-88E1-4E89-AD26-A833F83A09F0Q36662274-5D477E45-BA60-49AF-96C0-DECB226B2DB7Q36945591-A6B93E5E-17FC-45F9-BD94-18672E1E0D93Q36963993-BE092EE3-2D57-40F1-A663-E20CA57BA424Q37150461-52A5787D-27B4-46E0-A6D1-E1F560494372Q37177099-D69B3B56-B063-4206-9E9A-44A00EC880FFQ37309704-9152CB28-149D-4FA6-A625-ADB0D057CF4BQ37362664-53C74B37-3CE5-47E0-AD27-0932E8F5448A
P2860
Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@ast
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@en
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@nl
type
label
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@ast
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@en
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@nl
prefLabel
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@ast
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@en
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@nl
P2093
P1476
Sublingual immunotherapy with ...... allergic rhinoconjunctivitis.
@en
P2093
Martin R Pedersen
Niels Johansen
Sabina Rak
Stephen R Durham
William H Yang
P304
P356
10.1016/J.JACI.2005.12.1358
P407
P577
2006-04-01T00:00:00Z